, and a large number of Ca 2ϩ driven alterations in cell physiology can be mapped to its Ca 2ϩ sensing activity. CaM coordinates Ca 2ϩ ions through specialized EF-hand domains, and a large number of related proteins have now been characterized. In neurons, these include the neuronal calcium sensor (NCS) family of Ca 2ϩ -binding proteins (12). More recently, a group of CaM-like proteins, termed caldendrins (13, 14) or calciumbinding proteins (CaBPs) (15) have been identified that are vertebrate-specific and display a predominantly neuronal/retinal pattern of expression (14 -16). It has since been reported that members of the CaBP family are able to interact with and modulate the activity of InsP 3 Rs (17). Uniquely, it has been suggested that CaBPs may be capable of activating the InsP 3 R independently of the natural ligand ‡ To whom all correspondence should be addressed. 
Calcium is a ubiquitous intracellular second messenger in all vertebrate cells (1) . Intracellular resting free Ca 2ϩ concentration ([Ca 2ϩ ] i ) is acutely maintained at around 100 nM via a variety of mechanisms, and even small local rises above this base line are able to elicit dramatic cellular responses. Rises in [Ca 2ϩ ] i are generated through two primary routes (2) . First, many physiological agonists activate Ca 2ϩ channels that mediate the direct entry of extracellular Ca 2ϩ . Second, [Ca 2ϩ ] i can be elevated through release of sequestered Ca 2ϩ from intracellular stores (3) , most notably the endoplasmic reticulum (ER). 1 Ca 2ϩ release from intracellular stores is controlled predominantly by two related Ca 2ϩ channel families, the inositol 1,4,5-trisphosphate (InsP 3 ) receptor (InsP 3 R) and the ryanodine receptor (RyR). InsP 3 Rs couple to extracellular stimuli that drive the activation of phospholipase C and subsequent liberation of the soluble second messenger InsP 3. Activation of ER-localized InsP 3 Rs by InsP 3 in turn elicits Ca 2ϩ release into the cytosol. InsP 3 R activity can be further modulated by direct binding of Ca 2ϩ itself, and this regulation explains a form of calciuminduced calcium release that is responsible for the establishment of complex regenerative Ca 2ϩ signals within cells (2) . In neurons, such Ca 2ϩ signals have been intimately linked to processes as divergent as neurodegeneration, neurite outgrowth, alterations in neuronal gene expression, and neurotransmitter release (4 -10) . Factors affecting the generation and propagation of intracellular Ca 2ϩ signals therefore represent potential critical integrators of neuronal responses to complex and varied stimuli.
Although Ca 2ϩ is capable of eliciting direct cellular responses such as the aforementioned gating of InsP 3 Rs, many of its effects are registered indirectly through specific Ca 2ϩ -binding proteins. Calmodulin (CaM) is a universal Ca 2ϩ -binding protein, homologues of which are present in all eukaryotes (11) , and a large number of Ca 2ϩ driven alterations in cell physiology can be mapped to its Ca 2ϩ sensing activity. CaM coordinates Ca 2ϩ ions through specialized EF-hand domains, and a large number of related proteins have now been characterized. In neurons, these include the neuronal calcium sensor (NCS) family of Ca 2ϩ -binding proteins (12) . More recently, a group of CaM-like proteins, termed caldendrins (13, 14) or calciumbinding proteins (CaBPs) (15) have been identified that are vertebrate-specific and display a predominantly neuronal/retinal pattern of expression (14 -16) . It has since been reported that members of the CaBP family are able to interact with and modulate the activity of InsP 3 Rs (17) . Uniquely, it has been suggested that CaBPs may be capable of activating the InsP 3 R independently of the natural ligand InsP 3 . The ability to release stored Ca 2ϩ in the absence of InsP 3 production represents a potentially important new mechanism for the generation of intracellular Ca 2ϩ signals in neuronal cell types. It has also been proposed that CaBPs may additionally harbor the capacity to negatively regulate influx of extracellular Ca 2ϩ through a direct inhibitory interaction with plasma membrane P/Q type Ca 2ϩ channels (18 2ϩ signals in the model neuroendocrine PC12 cell system. We show by Western blotting and immunofluorescence that endogenous L-CaBP1 is detectable in PC12 cells and that a recombinantly expressed form of the protein is able to bind Ca 2ϩ in vitro with high affinity. An overexpressed, EYFP-tagged, version of L-CaBP1 displays a dual plasma membrane/perinuclear localization in PC12 cells, which mirrors the localization of the endogenous protein. It seems likely that the wild-type protein is myristoylated in vivo, since mutation of its putative N-terminal myristoylation motif causes a complete abolition of membrane association. In addition, the localization of both InsP 3 R1 and InsP 3 R3 with L-CaBP1-EYFP has been studied. Using pulldown type in vitro experiments, we also show that recombinant GST-L-CaBP1 is able to specifically interact with the type I InsP 3 R and the Ca v 2.1-␣ 1A channel subunit from rat brain extracts in a Ca 2ϩ -dependent manner. Furthermore, we have applied confocal imaging to monitor intracellular Ca 2ϩ responses in cells overexpressing L-CaBP1, a truncated version of this protein (Tr-CaBP1), and the related neuronal Ca 2ϩ -sensing protein, NCS-1. The data presented show that, in vivo, in neuroendocrine cells that endogenously express L-CaBP1, overexpression of the protein dramatically inhibits intracellular Ca 2ϩ rises due to release from InsP 3 R-sensitive intracellular stores.
MATERIALS AND METHODS
Cloning of DNA Constructs-The long form of human CaBP1 (LCaBP1; GenBank™ accession number AF169149) was amplified by PCR from human brain cDNA (Clontech, Palo Alto, CA) using an Omn-E dry block thermocycler (Hybaid, Middlesex, UK) and Bio-X-Act DNA polymerase (Bioline, London, UK) with primers containing restriction endonuclease sites (underlined) for subsequent cloning: sense (HindIII), 5Ј-GCCGAAGCTTATGGGCAACTGTGTCAAGTATCC-3Ј; antisense (SacII), 5Ј-GCCGCCGCGGGCGGGACATCATCCGGAC-3Ј; sense (BamHI), 5Ј-GCCGGGATCCATGGGCAACTGTGTCAAGTATC-C-3Ј; antisense (XhoI), 5Ј-GCCGCTCGAGTCAGCGGGACATCA-TCCGGAC-3Ј.
Tr-CaBP1 was amplified by PCR from the wild-type template using the following primers containing restriction endonuclease sites (underlined) for subsequent cloning: sense (HindIII): 5Ј-GCCGAAGCTTCTG-CGACCAGAGGAAATTG-3Ј; antisense (SacII), 5Ј-GCCGCCGCGGGC-GGGACATCATCCGGAC-3Ј; sense (BamHI), 5Ј-GCCGGGATCCCTGC-GACCAGAGGAAATTG-3Ј; antisense (XhoI), 5Ј-GCCGCTCGAGTC-AGCGGGACATCATCCGGAC-3Ј.
HindIII/SacII-digested PCR products were ligated into EYFP-N1 (Clontech) for imaging and immunofluorescence studies. BamHI/XhoIdigested PCR products were ligated into pGex-6P-1 (Amersham Biosciences) for recombinant protein expression. BamHI/XhoI-digested LCaBP1 PCR product was additionally ligated into pcDNA3.1(ϩ) (Invitrogen) for expression of untagged protein.
NCS-1 was amplified by PCR from an existing expression construct (19) using the following primers for subsequent subcloning into the pGex-6P-1 vector: sense (BamHI), 5Ј-GCCGGGATCCATGGGGAAATC-CAACAGCAAG-3Ј; antisense (XhoI), 5Ј-GCCGCTCGAGCTATAC-CAGCCCGTCGTAGAG-3Ј.
The CaBP1-EYFP(G2A) mutant was generated from wild-type CaBP1-EYFP template by site-directed mutagenesis using the QuikChange™ system (Stratagene, La Jolla, CA). The primers were as follows: sense, 5Ј-CTCGAGCTCAAGCTTATGG(G/C)CAACTGTGTCA-AGTATC-3Ј; antisense, 5Ј-GATACTTGACACAGTTG(C/G)CCATAA-GCTTGAGCTCGAG-3Ј.
Nucleotides in parentheses indicate bases that were changed to generate the appropriate amino acid substitution. All DNA constructs were checked by automated sequencing (Oswel, Southampton, UK).
Expression and Purification of GST-tagged Proteins-pGex-LCaBP1, pGex-Tr-CaBP1, and pGex-NCS-1 plasmids were transformed into BL-21 (DE3) Escherichia coli (Stratagene), and protein expression was induced with 1 mM isopropyl-1-thio-␤-D-galactopyranoside for 3 h at 37°C. Proteins were purified from cytosolic fractions on glutathioneSepharose (Amersham Biosciences). For proteolytic removal of the GST moiety, glutathione-Sepharose beads with bound GST fusion proteins were washed extensively in prescission buffer (50 mM Tris-HCl (pH 7.0), 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol) and then incubated with 40 units of prescission protease (Amersham Biosciences) overnight at 4°C with constant agitation. Supernatants containing GST-free protein were collected following centrifugation.
Fluorescence Measurements of Ca 2ϩ Binding to L-CaBP1 and NCS-1-GST-free NCS-1 and L-CaBP1 (both at 1 M) were incubated in Ca 2ϩ -free buffer (20 mM HEPES (pH 7.4), 139 mM NaCl, 5 mM EGTA, 5 mM nitrilotriacetic acid). An emission spectrum was obtained by excitation of protein samples at 280 nm and collection of emission fluorescence between 290 and 410 nm using an LS-5 luminescence spectrometer (PerkinElmer Life Sciences). CaCl 2 was then added stepwise to samples, with mixing, to give calculated free Ca 2ϩ concentrations ranging from 0.1 to 10 M (19). After each addition of Ca 2ϩ , a new spectrum was obtained as described above. Buffer alone and buffer plus 10 M free Ca 2ϩ control spectra were obtained using the same protocol. Percentages of Ca 2ϩ -dependent changes in peak fluorescence intensity were then calculated and plotted as a function of free Ca 2ϩ concentration.
Binding of GST-L-CaBP1 to Rat Brain Membrane Protein Extracts-
Rat brain membrane protein fractions were prepared as previously described (20) . GST-L-CaBP1, GST-NCS-1, or GST (all at 1 M) were immobilized onto 50 l of glutathione-Sepharose that had been prewashed in membrane buffer (25 mM Tris-HCl (pH 7.8), 50 mM KCl, 5 mM EGTA, 5 mM nitrilotriacetic acid, 1 mM dithiothreitol, 1% (v/v) Triton X-100) with or without 1 M free Ca 2ϩ by incubation for 30 min at 4°C. 500 l of rat brain membrane protein extract containing 0 or 1 M free Ca 2ϩ was then added to the appropriate samples, and binding was allowed to proceed for 2 h at 4°C with constant agitation. Sepharose pellets were collected by centrifugation and washed extensively in the binding buffer. Final pellets were extracted in 50 l of SDS dissociation buffer (125 mM HEPES (pH 6.8), 10% (w/v) sucrose, 10% (v/v) glycerol, 4% (w/v) SDS, 1% (v/v) ␤-mercaptoethanol, 2 mM EDTA), and samples were boiled for 5 min. Bound proteins were analyzed on SDS-PAGE (12.5% gel), and proteins were transferred to nitrocellulose membranes for immunoblotting via transverse electrophoresis. Proteins were detected with anti-InsP 3 R1 antibody (1:500; Affinity Bioreagents, Golden, CO) or anti-Ca v 2.1-␣ 1A (1:500; Sigma) and visualized using ECL-Plus reagents (Amersham Biosciences).
Production of Anti-CaBP1 Antiserum-Anti-CaBP1 was raised against the prescission-cleaved, GST-free form of recombinant L-CaBP1 by immunization of rabbits with 100 g of protein/animal (CovalAb, Cambridge, UK) and affinity-purified by binding to recombinant protein and elution before use.
Localization of EYFP and ECFP Constructs and Immunofluorescence-PC12 cells (0.25 ϫ 10 6 cells/well) were plated onto collagencoated glass coverslips and transiently transfected with 1 g of either EYFP-N1 control plasmid or 1 g of CaBP1-EYFP, Tr-CaBP1-EYFP, or L-CaBP1 (G2A)-EYFP constructs using LipofectAMINE 2000 reagent (Invitrogen) according to the manufacturer's protocol. For co-localization of CaBP1-EYFP with NCS-1-ECFP (21) or ECFP-ER (Clontech), cells were transfected with 1 g of each construct. 24 h following transfection, cells were fixed in 4% formaldehyde in PBS for 30 min. For staining of endogenous L-CaBP1 or co-staining experiments with InsP 3 R1 or InsP 3 R3 antibodies, cells were then incubated in PBT (phosphate-buffered saline plus 0.1% (v/v) Triton X-100 and 0.3% (w/v) bovine serum albumin) for 30 min. Cells were subsequently incubated with anti-CaBP1 (1:50), anti-InsP 3 R1 (1:50), or anti-InsP 3 R3 (1:50, BD Biosciences, Oxford, UK) followed by incubation with an appropriate species-specific biotin-conjugated secondary antibody (1:100; Amersham Biosciences). Cells were then washed and incubated with a streptavidin-Texas Red-conjugated tertiary antibody (1:50; Amersham Biosciences) prior to mounting of coverslips onto glass slides. All images were captured using laser-scanning confocal microscopy with a Leica TCS-SP-MP microscope (Leica Microsystems, Heidelberg, Germany) using a 22-m pin hole and a ϫ63 water immersion objective with a 1.2 numerical aperture. For optimal imaging of the spatial distribution of EYFP, the cells were excited at 514 nm and light was collected at 545-625 nm. Texas Red was imaged using excitation at 543 nm and light collection at 600 -650 nm. For dual imaging of EYFP and ECFP, the cells were excited at 514 nm with light collected at 560 -600 nm for EYFP or excited at 458 nm with light collected at 465-500 nm for ECFP detection. Images were exported as Tiff files and compiled in CorelDraw.
Imaging of Intracellular [Ca 2ϩ ] in PC12 Cells-PC12 cells (0.75 ϫ 10 6 cells/well) were plated onto collagen-coated glass coverslips and transiently transfected with 2 g of either EYFP-N1 control plasmid or 2 g of CaBP1-EYFP, Tr-CaBP1-EYFP, L-CaBP1(G2A)-EYFP, or NCS-1-EYFP constructs using LipofectAMINE 2000 reagent (Invitrogen) according to the manufacturer's protocol. 24 -48 h post-transfection, cells were washed in Krebs buffer (20 mM HEPES (pH 7.4), 145 mM NaCl, 10 mM glucose, 5 mM KCl, 2 mM CaCl 2 , 1.3 mM MgCl 2 , 1.2 mM NaH 2 PO 4 ) and then incubated with 1 M X-rhod-1 AM (Molecular Probes Europe BV, Leiden, The Netherlands) in Krebs buffer for 30 min at room temperature. Cells were washed extensively in Krebs buffer before imaging using laser-scanning confocal microscopy. An EYFP image was taken prior to each experiment to permit distinction between transfected/untransfected cells. X-rhod-1 was imaged using the Leica TCS-SP-MP microscope with excitation at 543 nm and light collection at 600 -650 nm. X-rhod-1 was used in the study of PC12 cells rather than Fura Red (22) , since the latter dye could not be successfully loaded into PC12 cells, and other dyes were not compatible with measurements in EYFP-expressing cells. The X-rhod-1 fluorescence was diffusely and uniformly distributed, suggesting cytosolic localization of the probe. 
RESULTS

Expression of Recombinant Proteins, Analysis of Ca
2ϩ Binding, and Interactions with InsP 3 R1 and Ca v 2.1␣ 1A -In order to examine the in vitro biochemical properties of L-CaBP1, we generated a series of GST fusion protein constructs that were purified from E. coli lysates. Fig. 1A depicts SDS-PAGE analysis of the purified versions of GST-NCS-1, GST-L-CaBP1, and GST-Tr-CaBP1 (lanes 1-3) . Tr-CaBP1 corresponds to c-CaBP1 as used in the study by Yang et al. (17) . This construct represents an N-terminally truncated version of the short form splice variant of CaBP1 (15) A, SDS-PAGE analysis of GST fusion proteins and their GST-free forms. Recombinantly expressed GST-NCS-1, GST-L-CaBP1, and GST-Tr-CaBP1 (1 g of each) were separated on a 12.5% gel and visualized via Coomassie Blue staining (lanes 1-3) . Prescission-cleaved, GST-free forms of recombinant NCS-1, L-CaBP1, and TrCaBP1 were analyzed on the same gel (lanes 4 -6) . B, changes in fluorescence emission on binding of Ca 2ϩ to prescission-cleaved, GST-free, NCS-1, and L-CaBP1. 1 M NCS-1 or 1 M L-CaBP1 were excited at 280 nm, and emission spectra were collected between 290 and 410 nm. Spectra were collected over a rangeoffreeCa 2ϩ concentrations,andCa 2ϩ -dependent changes in peak fluorescence (a rise for NCS-1 and a decline for LCaBP1) were plotted as a function of free Ca 2ϩ concentration. C and D, binding of GST-L-CaBP1 to InsP 3 R1 (Anti-IP 3 RI) and the Ca v 2.1-␣ 1A (Anti-P/Q␣ 1A ) channel subunit from rat brain membrane pro- GST-free forms of the recombinantly expressed proteins, which were obtained by proteolytic cleavage of the GST fusion constructs. We used the same proteolytic treatment to generate GST-free forms of L-CaBP1, Tr-CaBP1, and NCS-1 (Fig. 1A , lanes 4 -6) . It is apparent from PAGE analysis that proteolytic removal of GST was efficient for both NCS-1 and L-CaBP1 (Fig.  1A, lanes 4 and 5) . In contrast, similar treatment of Tr-CaBP1 resulted in severe degradation of the protein, formation of high molecular weight aggregates, and almost no recovery of the GST-free form (Fig. 1A, lane 6) .
Binding of Ca 2ϩ to the GST-free forms of both L-CaBP1 and NCS-1 was examined in vitro by monitoring changes in protein conformation upon Ca 2ϩ binding (24) as determined by alterations in tryptophan (NCS-1) or tyrosine (L-CaBP1) fluorescence emission spectra (Fig. 1B) . From these experiments, it is clear that both NCS-1 and L-CaBP1 are capable, in vitro, of binding Ca 2ϩ with affinities in the submicromolar range (K D for both L-CaBP1 and NCS-1 was between 0.1 and 0.3 M free Ca 2ϩ ). This demonstrates that binding of Ca 2ϩ to L-CaBP1 is of high affinity and drives a significant conformational change in the protein.
Recent reports have suggested that L-CaBP1 is able to interact with plasma membrane P/Q type Ca 2ϩ channels (18) and that Tr-CaBP1 is able to interact with InsP 3 R types 1 and 3 (17) . These reports are somewhat confusing in that the interaction with P/Q type channels appears to be independent of Ca 2ϩ , and interactions of Tr-CaBP1 with InsP 3 Rs involve binding to a form of CaBP1 that is not expressed endogenously in cells. In an attempt to resolve these issues, we analyzed the binding of GST-L-CaBP1 to rat brain protein extracts in the absence or presence of 1 M free Ca 2ϩ . In our hands, GST-LCaBP1 seemed to interact with both the InsP 3 R1 and the ␣ 1A subunit of the P/Q type Ca 2ϩ channel in an acutely Ca 2ϩ -dependent manner (Fig. 1, C and D) . InsP 3 R1 was present in rat brain membrane protein extracts (Fig. 1C, lane 1) (26) and bound to GST-L-CaBP1 only in the presence of free Ca 2ϩ (Fig.  1C, lane 4 versus lane 5) . This interaction was specific for L-CaBP1, since no binding was observed to GST-NCS-1 in either the presence or absence of free Ca 2ϩ (Fig. 1C, lanes 2 and  3) . Samples from the same binding experiments were also probed with an antibody specific for the ␣ 1A subunit of the P/Q type Ca 2ϩ channel (Fig. 1D) . Binding of GST-L-CaBP1 to the ␣ 1A subunit was observable only in the presence of free Ca 2ϩ (Fig. 1D, lanes 5 and 6 versus lanes 7 and 8) . This association was specific for GST-L-CaBP1, since no binding was observable to control GST protein in either the presence or absence of free Ca 2ϩ (Fig. 1D, lanes 1-4) . Localization of Endogenous and Overexpressed CaBP1 in PC12 Cells-Initial localization studies concerning CaBP1 (15) indicated that L-CaBP1 was most likely associated with cytoskeletal structures and that the splice variant S-CaBP1 was most likely with the plasma membrane. These experiments employed overexpression in CHO cells, and it is unlikely that L-CaBP1 is an endogenously occurring protein in this cell line. PC12 cells represent a neuroendocrine model cell line, and with the knowledge that L-CaBP1 displays a predominantly neuronal/retinal pattern of expression, we aimed to examine its expression/localization in this system. To confirm that PC12 cells represent a legitimate model system in which to study CaBP1 function, we first tested for the presence of endogenously expressed protein. GST-free L-CaBP1 was used to generate an anti-CaBP1 antibody for use in these studies. In immunofluorescence experiments on untransfected PC12 cells, anti-CaBP1 immunoreactivity was detected most strongly at the plasma membrane but was also present intracellularly (Fig. 2B, anti-CaBP1) . Western blotting of rat brain and PC12 cell lysates with anti-CaBP1 led to the detection of two species ( Fig. 2A ) with molecular masses of ϳ33 and 28 kDa, respectively. L-CaBP1 is itself a splice variant of the larger neuronal Ca 2ϩ -binding protein caldendrin (13) . Antisera raised against L-CaBP1 will therefore almost certainly detect caldendrin, if present, and previous studies examining the distribution of these proteins have indicated that the 33-kDa species is likely to represent caldendrin, with the smaller 28-kDa protein corresponding to L-CaBP1 (27) . Our data confirm these findings and show that both caldendrin and L-CaBP1 are present at similar levels in PC12 cells.
Further localization studies were conducted using EYFPtagged versions of L-CaBP1, Tr-CaBP1, and L-CaBP1 (G2A) and overexpression in PC12 cells. L-CaBP1 (G2A) represents a mutant version of L-CaBP1 where the glycine residue at position 2 of the protein sequence was mutated to alanine. In wild-type L-CaBP1, glycine 2 represents a putative site for myristoylation of the protein, and we therefore used this mutant to examine whether this modification was likely to occur under in vivo conditions. L-CaBP1-EYFP appeared to be localized mainly at the plasma membrane in PC12 cells and was also seen in a perinuclear region in favorable confocal sections (Fig. 3, L-CaBP1 ). This localization correlates well with that observed for endogenous L-CaBP1 expression (Fig. 2, antiCaBP1 ). In contrast, control EYFP-transfected cells displayed a diffuse cytosolic signal (Fig. 3, EYFP) . Tr-CaBP1-EYFP and L-CaBP1 (G2A)-EYFP both displayed a diffuse cytosolic distribution that was similar to EYFP control expression (Fig. 3 , Tr-CaBP1 and L-CaBP1 (G2A)). As aforementioned, Tr-CaBP1 lacks the putative myristoylation motif of the short form splice variant of L-CaBP1; similarly, L-CaL-CaBP1 (G2A) lacks the putative myristoylation motif of L-CaBP1. The fact that both of these constructs showed a diffuse cytosolic distribution compared with the well defined plasma membrane/perinuclear localization of L-CaBP1 would tend to suggest that, in vivo, L-CaBP1 is indeed myristoylated and that this modification is involved in targeting of the protein to specific membrane domains. The localization of L-CaBP-1-EYFP to the plasma membrane and a perinuclear compartment was reminiscent of myristoylated NCS-1, which is localized to the plasma membrane and the trans-Golgi network in PC12 and other cell types (21, 22, 28, 29) . In cells co-transfected to express L-CaBP1-EYFP (Fig. 4A, L-CaBP1 ) and NCS-1-ECFP (Fig. 4A, NCS-1) , the two proteins showed essentially complete overlap (Fig. 4A, overlay) .
The most intriguing report concerning CaBP1 function relates to its potential role as an InsP 3 of the receptor that have previously been demonstrated to bind GST-Tr-CaBP1. We compared, therefore, the localization of L-CaBP1-EYFP with these two receptor subtypes in PC12 cells using receptor-specific antibodies. InsP 3 R1 (Fig. 4B, InsP 3 RI) and InsP 3 R3 (Fig. 4C, InsP 3 RIII) displayed a punctate distribution throughout the PC12 cells. The distribution of both InsP 3 R1 and InsP 3 R3 may reflect their presumed localization to regions of the ER; however, neither receptor showed obvious extensive co-localization with L-CaBP1 (Fig. 4, B and C, overlap) . CaBP1 also failed to show any obvious extensive co-localization with a general ER content marker tagged with ECFP in live cells (Fig. 4D) .
The Effect of L-CaBP1 Overexpression on ATP-stimulated [Ca 2ϩ ] i Elevation in PC12 Cells-Through the application of selective purinergic receptor agonists, it is possible, with PC12 cells, to activate simultaneous entry of extracellular Ca 2ϩ and release from InsP 3 -dependent intracellular stores (ATP as agonist) or to activate release solely from the InsP 3 -dependent stores (UTP as agonist) (31, 32) . We therefore attempted to dissect the likely mode of action of overexpressed L-CaBP1, Tr-CaBP1, and L-CaBP1 (G2A) with respect to InsP 3 R function, in PC12 cells, by examining alterations in [Ca 2ϩ ] i in response to stimulation by ATP or UTP. In cells overexpressing EYFP protein alone, robust [Ca 2ϩ ] i rises in response to application of 100 M ATP were observed, which were almost identical to responses recorded from control, nontransfected cells monitored simultaneously (Fig. 5A ). This result suggests that transfection and overexpression of EYFP does not adversely affect normal rises in [Ca 2ϩ ] i . Averaged peak responses from a number of cells (Fig. 5A) confirmed that there was no statistically significant difference in [Ca 2ϩ ] i responses to ATP between EYFP-transfected and nontransfected cells. In contrast, overexpression of L-CaBP1-EYFP elicited a dramatic inhibitory effect on ATP-evoked elevation of [Ca 2ϩ ] i (Fig. 5B) . Averaged responses from L-CaBP1-EYFP-transfected versus nontransfected control cells from the same experiment (Fig. 5B) indicated that L-CaBP1 reduced the peak rises in [Ca 2ϩ ] i by 66% compared with control cells.
Previous work has suggested a stimulatory rather than inhibitory role for CaBP1 (17) . One possibility is that the inhibitory effect we observed was a consequence of the presence of the C-terminal EYFP tag on the expressed L-CaBP1 modifying the protein function. We therefore also tested the effects of untagged L-CaBP1 expressed from a pcDNA3-based construct. In this case, the PC12 cells were co-transfected with a second plasmid encoding EYFP for their identification. Such an approach with PC12 cells results in co-expression of both proteins in at least 95% of cells (33) . In these experiments, L-CaBP1 produced a 46% inhibition (Supplemental Fig. 1 (17) . Having observed that L-CaBP1 is able to exert a dramatic inhibitory effect on rises in [Ca 2ϩ ] i in intact PC12 cells, we decided to test whether Tr-CaBP1 would behave in a similar manner in this system. We also aimed to test whether myristoylation of L-CaBP1 is likely to be of importance to its inhibitory mode of action by analyzing the effect of L-CaBP1 (G2A) on ATP-driven rises in (Fig. 6A) . Averaged peak responses to ATP for TrCaBP1-EYFP-transfected versus nontransfected, control cells from the same experiment (Fig. 6A) indicated that Tr-CaBP1 inhibited the rises in [Ca 2ϩ ] i to a similar magnitude as for L-CaBP1 (average inhibition was 64%). Similarly, overexpression of L-CaBP1 (G2A)-EYFP also led to an inhibition of ATPevoked [Ca 2ϩ ] i rises compared with control, nontransfected cells (Fig. 6B) . Average peak responses indicated that this mutant induced a 44% suppression of the ATP-induced rise in [Ca 2ϩ ] i , which is less dramatic than for L-CaBP1 or Tr-CaBP1 but nonetheless represents a significant blockade of the Ca 2ϩ signal. The observed inhibitory effects of all CaBP1 constructs tested could simply be attributed to a Ca 2ϩ buffering artifact resulting from overexpression of a protein that has a high affinity for Ca 2ϩ . In order to rule out this possibility, we also tested the effect of overexpression of the related Ca 2ϩ -sensing protein, NCS-1 (12) . It is clear that NCS-1, in vitro, exhibits an affinity for Ca 2ϩ that is almost identical to L-CaBP1 (Fig. 1B) , has a closely similar localization (Fig. 4A) , and is also endogenously expressed in PC12 cells (19) and therefore represents an ideal control protein for these experiments. Overexpression of NCS-1-EYFP elicited no significant alteration in rises in [Ca 2ϩ ] i on stimulation with ATP (Fig. 6C) . Averaged peak response data from a population of cells confirmed this observation (Fig. 6C) . The finding that NCS-1 is unable to suppress rises in [Ca 2ϩ ] i in a similar fashion to the CaBP1 proteins suggests that the repression observed is due to a specific inhibitory function of the CaBPs and not a nonspecific Ca 2ϩ buffering effect.
The Effect of L-CaBP1 Overexpression on UTP and ATPstimulated [Ca 2ϩ ] i Elevation in PC12 Cells-In order to delineate more precisely the likely targets for CaBP1-mediated inhibition of [Ca 2ϩ ] i elevation, we utilized both ATP and UTP stimulation of PC12 cells to distinguish between entry through plasma membrane Ca 2ϩ channels and release, via InsP 3 Rs, from intracellular stores. Application of 1 mM UTP to control, nontransfected cells (Fig. 6D) , generated an intracellular Ca 2ϩ transient that represents release of Ca 2ϩ from InsP 3 -gated intracellular stores (31, 32) . In contrast, overexpression of L-CaBP1-EYFP led to an almost complete abolition of the UTPevoked transient (Fig. 6D) . Averaged peak responses to UTP confirmed that CaBP1-EYFP was able to significantly inhibit responses to this agonist (Fig. 6D , the averaged inhibition was 70%). Application of ATP following initial stimulation with UTP generated a further [Ca 2ϩ ] i rise that is still inhibited in cells overexpressing L-CaBP1-EYFP (Fig. 6D) . Averaged responses to ATP stimulation indicate that, following UTP treatment, L-CaBP1-EYFP remained capable of inhibiting rises in [Ca 2ϩ ] i (Fig. 6D) . The percentage inhibition was lower than seen with UTP stimulation in the same cells, suggesting that the major target through which the protein is able to suppress rises in [Ca 2ϩ ] i is an InsP 3 R-dependent release from intracellular stores. One potential explanation for the observed inhibition of intracellular Ca 2ϩ release by L-CaBP1 would be if overexpression of the protein were somehow responsible for depleting Ca 2ϩ from the ER, which would lead to little or no release from stores on application of UTP. To address this question, we determined ER Ca brane of PC12 cells through application of the agent digitonin for a short time (23) . We employed an identical approach in experiments where cells overexpressing untagged L-CaBP1 and a marker for transfection (ECFP) were loaded with a low affinity Ca 2ϩ -sensitive fluorophore (Mag-fluo4) that partitions into intracellular compartments including the ER (34) . Cells were subsequently treated with digitonin to release cytosolic dye and then perfused with buffer containing InsP 3. The initial fluorescence intensities for Mag-fluo4 were the same in control and transfected cells (61.12 Ϯ 2.95 arbitrary fluorescence units in nontransfected cells (n ϭ 17) and 56.12 Ϯ 3.98 units in transfected cells (n ϭ 26)), suggesting that the luminal ER [Ca 2ϩ ] did not differ. Release of Ca 2ϩ from stores was then monitored as a decrease in fluorescence signal following application of InsP 3 . Application of low concentrations of InsP 3 to either control or transfected cells did not release more than minor amounts of ER Ca 2ϩ , suggesting that CaBP1 did not act as an activating ligand for InsP 3 receptors. (A lack of effect of low doses of InsP 3 in control cells may be due to a limitation in access to the cytosol in these mildly permeabilized cells or conversion of cytosolic InsP 3 to inactive forms.) The addition of 10 M InsP 3 to control, untransfected cells led to significant Ca 2ϩ release from the ER, but this effect was abolished or reduced in all L-CaBP1-transfected cells analyzed (Fig. 7) . Averaged responses to InsP 3 treatment from a population of cells confirmed that L-CaBP1 was able to significantly diminish release of intracellular Ca 2ϩ in response to direct InsP 3 challenge with an average inhibition of 75% (Fig. 7) .
The Effect of L-CaBP1 Overexpression on Histamine-evoked Intracellular Ca
2ϩ Oscillations in HeLa Cells-To test the general applicability of L-CaBP1 function, we decided to further analyze the effect of its expression in a nonneuronal cell line.
HeLa cells are unlikely to express endogenous L-CaBP1 and display well characterized [Ca 2ϩ ] i oscillations in response the agonist histamine (35, 36) . We therefore examined the consequence of L-CaBP1 expression on [Ca 2ϩ ] i rises in this system. In control, untransfected, cells, application of histamine induced a prolonged series of oscillatory fluctuations in [Ca 2ϩ ] i (Fig. 8) . In contrast, in cells expressing L-CaBP1-EYFP, histamine-evoked Ca ished (Fig. 8) . This result suggests that L-CaBP1 is capable of suppressing InsP 3 R-mediated [Ca 2ϩ ] i rises in a generalized manner and that its restricted pattern of expression lends functional specificity in neuronal/retinal tissues.
DISCUSSION
Many physiological processes driven by Ca 2ϩ are transduced by specific Ca 2ϩ -binding proteins (11, (37) (38) (39) . In recent years, new members of the CaM superfamily have been identified that appear to mediate particular signaling pathways in specific tissue and cell types (2, 12, 38) . One recently discovered CaM subfamily, the CaBPs (15), appear to display a predominantly neuronal pattern of expression, and early functional reports have inferred roles in the regulation of [Ca 2ϩ ] i (17, 18) . Forms of CaBP1 have been identified as InsP 3 -independent agonists of the InsP 3 R (17) . In this study, we have analyzed aspects of the basic biochemistry of L-CaBP1 in combination with functional studies employing the model neuroendocrine PC12 cell system to investigate the consequences of L-CaBP1 expression on intracellular Ca 2ϩ signals. Proteins that act as transducers of Ca 2ϩ signals switch conformation upon binding Ca 2ϩ (40) . Conversely, many proteins whose function is simply to buffer excess free Ca 2ϩ do not undergo significant changes in conformation upon Ca 2ϩ binding (40, 41) . We have monitored fluorescence emission spectra for both NCS-1 (24, 42) and L-CaBP1 in response to Ca 2ϩ binding and show that both proteins exhibit submicromolar binding affinities that are coupled to significant conformational alterations, providing evidence that L-CaBP1 exhibits characteristics in common with established sensors of intracellular Ca 2ϩ signals such as CaM and NCS-1. Forms of CaBP1 have been suggested to bind to both InsP 3 Rs and P/Q type voltage-gated Ca 2ϩ channels (17, 18) . We have investigated the interaction of L-CaBP1 with both of these channels and have determined that it is capable of binding to both InsP 3 R1 and the Ca v 2.1-␣ 1A channel subunit in a Ca 2ϩ -dependent fashion. These binding data, in conjunction with the determination of submicromolar Ca 2ϩ affinity, suggest that the recombinant L-CaBP1 construct used in these studies is fully functional in Ca 2ϩ binding and that this binding is important for interaction with target proteins. Association with the InsP 3 R1 receptor has already been reported to be Ca 2ϩ -dependent (17); however, interaction with the P/Q Ca v 2.1 channel was determined to be insensitive to Ca 2ϩ (18) . The reason for the discrepancy between our observations and the earlier report is unclear but may be due to differences in experimental procedure. Almost all current experimental data that have been generated concerning the localization and function of CaBP1 have either involved in vitro analyses or expression/application of the protein in systems where it does not endogenously occur. We therefore attempted to examine CaBP1 function in a more applicable in vivo system. PC12 cells represent a well characterized neuroendocrine cell line that has been applied to the study of various aspects of neuronal cell function, especially neurosecretion (43) . We have shown that these cells do express L-CaBP1, along with its larger splice isoform caldendrin, and that anti-L-CaBP1 antiserum prominently stains the plasma membrane region of these cells and intracellular structures. Due to cross-reactivity of the anti-L-CaBP1 antibody, at present we are unable to determine whether this staining derives entirely from L-CaBP1 or a combination of L-CaBP1 and caldendrin. However, an EYFP-tagged version of L-CaBP1 displays a very similar localization to that observed for the endogenous protein and in favorable confocal sections could be seen to be associated with perinuclear structures, probably the Golgi complex as seen for endogenous and exogenous NCS-1 in PC12 cells (21, 29) , which colocalizes with CaBP1.
Analysis of myristoylation-defective forms of L-CaBP1 (LCaBP1 (G2A) and Tr-CaBP1) suggests that the protein is indeed acylated in vivo and that this modification is essential for productive targeting to specific cellular membranes. In related studies, we have also examined the co-localization of L-CaBP1 with an ER specific marker and with the type 1 and 3 InsP 3 Rs. There was no obvious extensive co-localization of L-CaBP1 with any of these markers in PC12 cells. Previous work has demonstrated that endogenous CaBP1 can be immunoprecipitated with both types 1 and 3 IP 3 Rs from whole brain extracts (17) , providing strong evidence for a direct in vivo interaction between these proteins. It is likely, therefore, that the apparent discrepancy between the immunolocalization and binding assays is due to only a small proportion of expressed CaBP1 actually being associated with IP 3 Rs. It should be noted that there is growing evidence suggesting that InsP 3 Rs may be present on the Golgi apparatus (44) . The L-CaBP1 localizes to a perinuclear region in PC12 cells that is likely to correspond to the Golgi complex, and therefore this observation may warrant further investigation.
The most interesting feature of the CaBP1 protein relates to its reported ability to stimulate InsP 3 R-mediated Ca 2ϩ release in the absence of InsP 3 (17) . Since L-CaBP1 is endogenously expressed in PC12 cells, we examined the effects of L-CaBP1 expression on intracellular Ca 2ϩ release in these cells. Overexpression of L-CaBP1 dramatically inhibited both ATP-and UTP-evoked rises in [Ca 2ϩ ] i . These observations are consistent with L-CaBP1 exerting a direct inhibitory function on InsP 3 -gated Ca 2ϩ release from intracellular stores, although we are unable to formally dismiss a small inhibitory effect on influx of extracellular Ca 2ϩ . It seems likely that the effects exerted by L-CaBP1 are functionally relevant, since they were unaffected by removal of the EYFP tag, overexpression of the protein did not appear to alter loading of intracellular Ca 2ϩ stores as determined by thapsigargin treatment of transfected versus untransfected cells, and overexpression of the related Ca brane localization of the protein, is dispensable for the inhibitory effects observed in relation to agonist evoked [Ca 2ϩ ] i rises. The observation that largely nontargeted L-CaBP1 is able to almost abolish InsP 3 -mediated intracellular Ca 2ϩ release might be consistent with an overall lack of extensive co-localization of these proteins in vivo, suggestive instead of a small pool of IP 3 R-associated protein.
We furthered our functional studies to determine whether L-CaBP1 was capable of exerting a similar inhibitory phenotype on intracellular Ca 2ϩ signals in a cell line where the protein is not endogenously expressed. In HeLa cells, expression of L-CaBP1 almost completely abolished histamine-evoked intracellular Ca 2ϩ transients, suggesting that this protein may be capable of a more generalized inhibition of InsP 3 R-mediated intracellular Ca 2ϩ release. It seems likely that the restricted pattern of expression of L-CaBP1 is responsible for localizing its inhibitory function on InsP 3 Rs to specialized regions of the central nervous system; however, the physiological relevance of this activity remains to be investigated.
Initial reports concerning CaBP1 function hinted at a potentially important new mode of control for the generation of intracellular Ca 2ϩ signals mediated through InsP 3 R-governed stores (17) . Results from a model neuroendocrine cell system presented in this study confirm that L-CaBP1 is capable of binding to InsP 3 receptors and affecting Ca 2ϩ release from intracellular stores as originally suggested. Our data indicate, however, that the protein exerts an inhibitory rather than stimulatory effect during agonist-induced intracellular Ca 2ϩ signaling. The reasons for these converse results are not immediately clear. One possibility could relate to the stability of recombinant CaBP proteins, especially for truncated forms as found in the present study. Fragments derived from full-length CaBP1 could have altered functional effects. It should also be noted that the stimulatory effect of CaBP1 that was reported was not in an intact cell system and was seen with InsP 3 receptors of Xenopus, a species that does not appear to express CaBPs based on data base searches. CaBP1 has also been found to inhibit an alternative Ca 2ϩ -induced Ca 2ϩ release pathway (45) , although NCS-1 had a similar effect. In addition, results recently presented by Roderick et al. (46) also suggest that CaBP1 has an inhibitory action in nonneuronal COS cells. In other studies we have been unable to observe any activation of Ca 2ϩ responses following introduction of recombinant LCaBP1 into pancreatic acinar cells. 2 Overall, the accumulating evidence would appear to indicate that CaBP proteins are likely to be important new negative regulators in the control of intracellular Ca 2ϩ signals in neuronal tissues.
